Ignite Creation Date:
2025-12-24 @ 5:38 PM
Ignite Modification Date:
2026-03-17 @ 10:47 PM
Study NCT ID:
NCT07082868
Status:
RECRUITING
Last Update Posted:
2025-10-20
First Post:
2025-07-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Epcoritamab and Ibrutinib in People With Central Nervous System Lymphoma (CNSL)
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
25-032
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None